Chandra Vargeese

2018

In 2018, Chandra Vargeese earned a total compensation of $2.2M as Senior Vice President, Drug Discovery at Wave Life Sciences Ltd., a 88% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,200
Option Awards$899,918
Salary$400,000
Stock Awards$700,875
Other$10,572
Total$2,174,565

Vargeese received $899.9K in option awards, accounting for 41% of the total pay in 2018.

Vargeese also received $163.2K in non-equity incentive plan, $400K in salary, $700.9K in stock awards and $10.6K in other compensation.

Rankings

In 2018, Chandra Vargeese's compensation ranked 5,295th out of 14,244 executives tracked by ExecPay. In other words, Vargeese earned more than 62.8% of executives.

ClassificationRankingPercentile
All
5,295
out of 14,244
63rd
Division
Manufacturing
2,001
out of 5,759
65th
Major group
Chemicals And Allied Products
733
out of 2,122
66th
Industry group
Drugs
613
out of 1,811
66th
Industry
Pharmaceutical Preparations
473
out of 1,385
66th
Source: SEC filing on June 26, 2019.

Vargeese's colleagues

We found four more compensation records of executives who worked with Chandra Vargeese at Wave Life Sciences Ltd. in 2018.

2018

Paul Bolno

Wave Life Sciences Ltd.

Chief Executive Officer

2018

Michael Panzara

Wave Life Sciences Ltd.

Chief Medical Officer

2018

Keith Regnante

Wave Life Sciences Ltd.

Chief Financial Officer

2018

Christopher Francis

Wave Life Sciences Ltd.

Senior Vice President, Corporate Development, Head of Emerging Areas

News

You may also like